Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 16, Iss. 2, 2014-02 ,pp. : 143-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1201-1207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF‐Wii study; a multicentre randomized controlled trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 743-748

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 735-742

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial

By  

Cardiology, Vol. 136, Iss. 2, 2016-09 ,pp. : 128-137

Karger

Access to resources Recommend Favorite